Skip to main content
search

Parliamentary Debates and Questions

S5W-21703: Miles Briggs (Lothian)

Scottish Conservative and Unionist Party

Date lodged: 18 February 2019

To ask the Scottish Government what plans it has to review SIGN guideline 113 for the treatment of Parkinson’s disease.

Answered by: Joe FitzPatrick 27 February 2019

SIGN is part of the Evidence Directorate of Healthcare Improvement Scotland and receives core funding from Healthcare Improvement Scotland. It is editorially independent from Healthcare Improvement Scotland and the Scottish Government.

Any group or individual can propose or request a review of a SIGN guideline by completing a proposal form and returning it to the SIGN Executive. Guideline topics are selected on the basis of burden of disease, the existence of variation in practice, and the potential to improve outcomes. There is a defined process that SIGN follows to support proposers to develop their proposals and then selection criteria that aid the Guideline Programme Advisory Group to decide which proposals to accept for guideline development. The SIGN Council ratifies these accepted proposals.